☆ 4.6 Meeting Abstract

Sequencing of PD-1 Inhibitors and TKIs in Metastatic NSCLC with MET Exon 14 Skipping Mutation May Influence Survival

JOURNAL OF THORACIC ONCOLOGY (2021)

Add to Collection

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 16, Issue 10, Pages S1086-S1087

Publisher

ELSEVIER SCIENCE INC

Keywords

Immune checkpoint inhibitors; MET exon14; MET TKI

Categories

Oncology Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.